The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
49 reports and counting
Annexon Biosciences Raises $125M in Series D
Annexon Biosciences, a Biotech company based in 180 Kimball Way, South San Francisco, CA 94080, has raised $125M in Series D at a $750M valuation led by GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group.
Annexon Biosciences raises $125M Series D at $750M valuation
Annexon Biosciences raises $125M in Series D at $750M valuation. Classical complement pathway inhibitors...
Treeline Biosciences Raises $200M in Series A
Treeline Biosciences, a HealthTech company based in San Diego, CA, has raised $200M in Series A from multiple investors.
Serán Bioscience Raises $200M in Venture
Serán Bioscience, a Biotech company based in Bend, OR, has raised $200M in Venture at a $900M valuation led by Foresite Capital, OrbiMed.
Retro Biosciences Raises $1B in Seed
Retro Biosciences, a HealthTech company based in San Francisco, CA, has raised $1B in Seed led by Sandro Salsano.
Syndeio Biosciences Raises $90M in Series
Syndeio Biosciences, a Biotech company based in Indianapolis, IN, has raised $90M in Series at a $450M valuation led by Eli Lilly and Company, ARCH Venture Partners.
Ollin Biosciences Raises $100M in Series A
Ollin Biosciences, a Biotech company based in Austin, TX, has raised $100M in Series A at a $500M valuation led by Deerfield Management, ARCH Venture Partners.
Colossal Biosciences Raises $120M in Series
Colossal Biosciences, a Biotech company based in Austin, TX, has raised $120M in Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.
Merida Biosciences Raises $121M in Series A
Merida Biosciences, a Biotech company based in Cambridge, MA, has raised $121M in Series A at a $500M valuation led by Bain Capital Life Sciences, Biotechnology Value Fund, Third Rock Ventures.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.